Stoke Therapeutics Inc Cash Flow Quality Index

Latest as of March 2025: 1.17x

Stoke Therapeutics Inc cash flow quality index. Stoke Therapeutics Inc (STOK) has a Cash Flow Quality Index of 1.17x as of March 2025. Operating cash flow of $131.83 Million exceeds net income of $112.88 Million, indicating high earnings quality where cash backs reported profits. See Stoke Therapeutics Inc free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.

Cash Flow Quality Index

1.17x
Operating CF / Net Income

Operating Cash Flow

$131.83 Million
USD

Net Income

$112.88 Million
USD

Data as of

Mar 2025
Most recent filing

Stoke Therapeutics Inc Cash Flow Quality Index by Year (None–None)

Stoke Therapeutics Inc cash flow quality index by year from None to None. Year-by-year earnings quality comparison for Stoke Therapeutics Inc. For the full cash flow conversion analysis, see Stoke Therapeutics Inc (STOK) cash conversion ratio.

Year Quality Index Operating CF (USD) Net Income YoY Change
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.